NewGen Filed 2025 Annual Report on Form 20-F
Rhea-AI Summary
NewGenIVF Group (NASDAQ: NIVF) filed its 2025 Annual Report on Form 20-F for the fiscal year ended December 31, 2025. The filing was made with the U.S. Securities and Exchange Commission on April 1, 2026.
The annual report is available on the company’s investor relations website for investor review and regulatory transparency.
Positive
- None.
Negative
- None.
News Market Reaction – NIVF
In the Apr 1 session, NIVF declined 4.42%, reflecting a moderate negative market reaction. Argus tracked a trough of -5.2% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 02 | Strategic partnership | Positive | -5.7% | MOU for regional women’s health awareness and education initiative. |
| Feb 24 | Strategic update | Positive | +1.5% | Recap of diversification strategy and net assets position. |
| Feb 04 | Tokenized bond launch | Positive | -30.4% | Activation of commitment campaign for inaugural tokenized real estate bond. |
| Jan 27 | Share repurchase plan | Positive | -19.4% | Execution of up to US$2 million share repurchase program through Benchmark. |
| Jan 21 | Tokenization strategy | Positive | -4.6% | Appointment of Web3 counsel and engagement to launch up to USD 30M tokenized bonds. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent upbeat strategic and tokenization announcements have often been followed by negative price reactions, showing a pattern of divergence between news tone and trading.
Over the last few months, NewGen has focused on diversification and tokenization initiatives. In January–February 2026, it outlined a strategy including up to USD 30 million in tokenized bonds and a tokenized real estate bond campaign, yet several of these updates were followed by double-digit declines. A US$2 million share repurchase plan also preceded a sharp drop. Against this backdrop, today’s routine Form 20-F annual report filing appears more regulatory than strategic, contrasting with prior growth- and Web3-focused announcements.
Key Terms
form 20-f regulatory
securities and exchange commission regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
BANGKOK, April 01, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the “SEC”).
The annual report can be accessed on the Company’s investor relations website at https://investors.newgenivf.com.
About NewGenIVF Group Limited
NewGenIVF Group is a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through three strategic business divisions that leverage cutting-edge technology and innovative solutions to drive sustainable growth and high ROI for shareholders across multiple global markets. These include “NewGenProperty”, which was established to explore and operate lucrative real estate development projects in the UAE’s Ras Al Khaimah Emirate; “NewGenDigital”, which serves as the Company’s digital asset and DeFi solutions arm; and “NewGenSup”, which focuses on health and longevity products and solutions. NewGen’s legacy business involves providing industry-leading IVF and assisted reproductive treatment services across Asia. With operations spanning multiple jurisdictions and a commitment to innovative, technology-enabled solutions, NewGenIVF Group is uniquely positioned to capitalize on the convergence of real estate, healthcare and digital asset opportunities in the evolving global economy.
To learn more, visit www.nivf.global. The information contained on, or accessible through, NewGen’s website is not incorporated by reference into this press release, and you should not consider it a part of this press release.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar statements. Without limiting the generality of the foregoing, forward-looking statements in this press release include but are not limited to: statements regarding the Company's business strategy, growth prospects, and operations across its real estate development, digital asset, and reproductive health divisions.
Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. A number of factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the following: the Company's ability to execute its multi-division business strategy; regulatory, legal, and market challenges across the jurisdictions in which the Company operates; competitive pressures in the real estate, digital asset, and healthcare sectors; macroeconomic and geopolitical conditions affecting the Company's markets; and other risks and uncertainties detailed in the Company's annual report on Form 20-F and other filings with the Securities and Exchange Commission.
All information provided in this press release is as of the date of this press release, and NewGen does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: Newgenivf.IR@icrinc.com
